Canada Markets open in 3 hrs 14 mins

Eidos Therapeutics, Inc. (6MX.F)

Frankfurt - Frankfurt Delayed Price. Currency in EUR
Add to watchlist
36.200.00 (0.00%)
As of 8:00AM CEST. Market open.
Currency in EUR

Valuation Measures

Market Cap (intraday) 51.38B
Enterprise Value 31.24B
Trailing P/E N/A
Forward P/E 1N/A
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)51.77
Price/Book (mrq)9.35
Enterprise Value/Revenue 346.56
Enterprise Value/EBITDA 6-20.06

Trading Information

Stock Price History

Beta (5Y Monthly) -0.39
52-Week Change 315.65%
S&P500 52-Week Change 3N/A
52 Week High 358.93
52 Week Low 331.61
50-Day Moving Average 340.26
200-Day Moving Average 342.48

Share Statistics

Avg Vol (3 month) 33
Avg Vol (10 day) 310
Shares Outstanding 538.57M
Float 11M
% Held by Insiders 166.33%
% Held by Institutions 132.46%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Currency in USD.

Fiscal Year

Fiscal Year Ends Dec. 31, 2019
Most Recent Quarter (mrq)Jun. 30, 2020


Profit Margin -238.74%
Operating Margin (ttm)-233.04%

Management Effectiveness

Return on Assets (ttm)-23.85%
Return on Equity (ttm)-45.33%

Income Statement

Revenue (ttm)26.69M
Revenue Per Share (ttm)0.71
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)24.19M
EBITDA -61.97M
Net Income Avi to Common (ttm)-63.72M
Diluted EPS (ttm)-1.70
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)174.82M
Total Cash Per Share (mrq)4.53
Total Debt (mrq)21.4M
Total Debt/Equity (mrq)14.33
Current Ratio (mrq)11.62
Book Value Per Share (mrq)3.87

Cash Flow Statement

Operating Cash Flow (ttm)-46.45M
Levered Free Cash Flow (ttm)-22.84M